Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
150.00
+1.50 (1.01%)
Aug 5, 2026, 1:30 PM CST
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 15.27 billion as of August 5, 2026. Its market cap has increased by 12.43% in one year.
Market Cap
15.27B
Enterprise Value
14.13B
Revenue
1.03B
Ranking
n/a
PE Ratio
29.83
Stock Price
150.00
ChartMarket Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 15.27B, an increase of 199.55%. That is a compound annual growth rate of 15.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 15.27B | 6.26% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 21.79B |
| Sunmax Biotechnology | 20.86B |
| TaiMed Biologics | 15.55B |
| Medigen Vaccine Biologics | 15.40B |
| Lumosa Therapeutics | 14.72B |
| EirGenix | 13.96B |
| ACRO Biomedical | 13.32B |
| Tanvex BioPharma | 10.07B |